All Articles

A perfect storm of provider fee waivers and new tax credits is finally making 401(k)s affordable for small businesses, reshaping the battle for talent.

Mobix Labs posts a 54% revenue jump and slashes losses, but a volatile stock and aggressive M&A strategy raise questions about its long-term stability.

Fermi America's 11GW Texas energy campus will power AI, but its success hinges on an innovative hybrid cooling tech designed to protect a vital aquifer.

Youdao's 2025 Word of the Year reveals more than a search trend; it shows a nation's collective shift towards embracing an AI-powered future.

The appointment of a CNBC digital veteran to lead CoinDesk signals a pivotal shift. What does this mean for the future of crypto information and investment?

With FDA Breakthrough status, Ionis's olezarsen could transform care for millions with a dangerous lipid disorder by preventing life-threatening pancreatitis.

Akebia Therapeutics expands its pipeline, targeting rare kidney diseases with two novel drugs and offering new hope where treatment options are scarce.

A key investor sells John Wood Group shares below the approved takeover price. We decode the move and what it means for the engineering firm's future.

Clean Energy Fuels' new RNG facility turns farm waste into a carbon-negative asset, revealing a powerful strategy for institutional investors.

A private equity-backed firm is offering a 'Fortune 500' toolkit to save local auto shops. But does this empowerment come at the cost of independence?

CerraCap Ventures and Impact VC have merged, creating a new firm built on corporate access. Is this integrated model the future of startup acceleration?

With robust economics and U.S. government support, a New York mine is set to become a cornerstone of America's critical mineral independence strategy.

With a $50M Series A, Morphocell Technologies is advancing its revolutionary ReLiver® therapy, aiming to replace organ transplants with off-the-shelf tissue.

Amid a brutal market downturn, a routine rebalancing of a European crypto ETP reveals a deeper trend: the rise of regulated, diversified crypto investing.

Mini PC leader GEEKOM enters the ultralight laptop war with its GeekBook X14 Pro. Can its impressive specs and bold claims disrupt the giants?

A new multinational consortium is using lessons from Ukraine and advanced VR to revolutionize how allied forces train for the complexities of drone combat.

A new FDA-approved blood test is changing prostate cancer screening by reducing unnecessary biopsies, easing patient anxiety, and saving healthcare costs.

With a new CDO and £50M in funding, NRG Therapeutics is poised to advance its novel mitochondrial drug for neurodegenerative diseases into human trials.

How iGaming affiliate Bojoko turned strict UK regulations into a competitive advantage, achieving rapid growth by prioritizing transparency and trust.

Viasat's NexusWave upgrade promises revolutionary speeds, but it's a strategic move against Starlink amid high-stakes satellite deployment challenges.